'For the quarter ending Sept 2023, consolidated Net sales (including other operating income) of Dr Lal Pathlabs has increased 12.65% to Rs 601.3 crore compared to quarter ended Sept 2022. Operating profit margin has jumped from 26.94% to 29.57%, leading to 23.64% rise in operating profit to Rs 177.80 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 21.77% to 20.36%.   Employee cost increased from 17.03% to 17.53%.   Other expenses fell from 34.26% to 32.55%.   Selling and administration expenses rose from 13.92% to 14.17%.   

Other income rose 108.05% to Rs 18.1 crore.  PBIDT rose 28.46% to Rs 195.9 crore.  Provision for interest fell 28.44% to Rs 7.8 crore.  Loan funds rose to Rs 299.20 crore as of 30 September 2023 from Rs 285.40 crore as of 30 September 2022.  Inventories declined from Rs 54.50 crore as of 30 September 2022 to Rs...

• 

  (17-Aug-2024)

  AIA Engineering

  Net down 5% on lower sales

• 

  (17-Aug-2024)

  Voltas

  Net jump 159% on good operating show

• 

  (17-Aug-2024)

  ABB India

  Net up 50% on good operating show

• 

  (17-Aug-2024)

  NHPC

  Sales down 2%, net down 1%